Stefan Michiels
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 314 publications
Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.
Journal: British journal of cancer
Published: August 31, 2026
Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab.
Journal: JAMA oncology
Published: April 09, 2026
Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK Biobank.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 18, 2026
Use of clone-censor-weight to avoid immortal-time bias: a systematic methodological review.
Journal: Journal of clinical epidemiology
Published: March 13, 2026
Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.
Journal: The Lancet. Oncology
Published: January 11, 2026
Increments in physical activity relate to reductions in tinnitus severity: a 2-year prospective observational study.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: December 10, 2025
Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
Journal: The Lancet. Oncology
Published: November 17, 2025
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.
Journal: Lancet (London, England)
Published: October 06, 2025
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2025
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2025
Last Updated: 09/26/2026